# Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-183
- **Status:** posted
- **Opens:** November 26, 2024
- **Closes:** October 15, 2027
- **CFDA:** 93.242
- **View on Kontrakk:** https://kontrakk.com/grants/357430

## Description

No description provided.